Company intelligence / Profile preview

Arthesys

Ownership: Private
Development stage: Other

Overview

Arthesys developed and commercialized advanced vascular intervention devices including PTCA/ PTA catheters, aspiration catheters for thrombus removal, Y connectors/accessories for device insertion, and cobalt chromium stents. The company had over two decades of experience in the field with robust R&D and manufacturing capabilities. It was acquired by QMD Medical Devices ("QMD"), which now markets its products under the QMD brand.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

OEM/outsourcing partnerships with hospitals/doctors/device companies; now integrated into QMD's global network

Beyond the preview

Go deeper on Arthesys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arthesys.

Explore the full profile